Showing results (251-260 of 716) with videos related to

Sort By:
Pageof 72
Haematologica|March 2, 2011
Outcome of patients with chronic myeloid leukemia with multiple ABL1 kinase domain mutations receiving tyrosine kinase inhibitor therapyAlfonso Quintás-Cardama, Hagop Kantarjian, Susan O'Brien, et al.
The Lancet. Oncology|March 5, 2013
Two dosing regimens of tosedostat in elderly patients with relapsed or refractory acute myeloid leukaemia (OPAL): a randomised open-label phase 2 studyJorge Cortes, Eric Feldman, Karen Yee, et al.
Blood|April 12, 2008
Characteristics and outcomes of patients with chronic myeloid leukemia and T315I mutation following failure of imatinib mesylate therapyElias Jabbour, Hagop Kantarjian, Dan Jones, et al.
Haematologica|August 6, 2002
A phase I study of idarubicin dose escalation with amisfostine and high-dose cytarabine in patients with relapsed acute myelogenous leukemia and myelodysplastic syndromesGuillermo Garcia-Manero, Stefan Faderl, Francis Giles, et al.
Cancer|June 22, 2010
Outcome of patients with myelodysplastic syndrome after failure of decitabine therapyElias Jabbour, Guillermo Garcia-Manero, Nicolas Batty, et al.
Cancer|October 21, 2010
Long-term prognostic impact of the use of erythropoietic-stimulating agents in patients with chronic myeloid leukemia in chronic phase treated with imatinibFabio P S Santos, Yesid Alvarado, Hagop Kantarjian, et al.
Leukemia & Lymphoma|March 22, 2014
Omacetaxine mepesuccinate in patients with advanced chronic myeloid leukemia with resistance or intolerance to tyrosine kinase inhibitorsH Jean Khoury, Jorge Cortes, Michele Baccarani, et al.
British Journal of Haematology|March 11, 2004
Troxacitabine and imatinib mesylate combination therapy of chronic myeloid leukaemia: preclinical evaluationNada Orsolic, Francis J Giles, Henriette Gourdeau, et al.
Cancer|March 13, 2009
Bleeding diathesis in patients with chronic myelogenous leukemia receiving dasatinib therapyAlfonso Quintás-Cardama, Hagop Kantarjian, Farhad Ravandi, et al.
Cancer|October 11, 2008
Outcome of adults with acute lymphocytic leukemia after second salvage therapySusan O'Brien, Deborah Thomas, Farhad Ravandi, et al.
Pageof 72